Joshua R. Disbrow
2013 - Ampio Pharmaceuticals
In 2013, Joshua R. Disbrow earned a total compensation of $356.5K as Chief Operating Officer at Ampio Pharmaceuticals, a 66% decrease compared to previous year.
Compensation breakdown
| Bonus | $127,500 |
|---|---|
| Salary | $228,958 |
| Total | $356,458 |
Disbrow received $229K in salary, accounting for 64% of the total pay in 2013.
Disbrow also received $127.5K in bonus.
Rankings
In 2013, Joshua R. Disbrow's compensation ranked 10,380th out of 12,286 executives tracked by ExecPay. In other words, Disbrow earned more than 15.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,380 out of 12,286 | 16th |
Division Manufacturing | 3,865 out of 4,612 | 16th |
Major group Chemicals And Allied Products | 1,231 out of 1,466 | 16th |
Industry group Drugs | 970 out of 1,160 | 16th |
Industry Pharmaceutical Preparations | 753 out of 890 | 15th |
Source: SEC filing on August 15, 2014.
Disbrow's colleagues
We found four more compensation records of executives who worked with Joshua R. Disbrow at Ampio Pharmaceuticals in 2013.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019